iSpecimen receives Nasdaq deficiency notice for bid price below $1.00; cure deadline May 18, 2026

iSpecimen Inc.

Notice received Nov 19, 2025; stock continues trading under ISPC with no immediate delisting.
Company has 180 calendar days, until May 18, 2026, to regain compliance.
To cure, closing bid price must be at least $1.00 for ten consecutive business days.
If not cured by May 18, 2026, an additional 180-day period may be available if other listing criteria are met.
Options include a reverse stock split; failure to cure could lead to delisting and appeal rights.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.